|
I Blocked D2 and All I Got Was This Lousy Side Effect: What to Do When D2 Isn’t Enough
Andrew J Cutler, MD
Given the high rates of treatment resistance and relapse in schizophrenia, and the implications in terms of patient outcomes, novel strategies and therapeutic approaches beyond D2 receptor blockade are being intensively studied. In this presentation, Dr. Andrew Cutler provides the most current information on pharmacological treatment options beyond targeting the D2 receptor, along with novel pharmaceutical approaches that involve other neurotransmitter systems, instead of dopamine.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Preventing Relapse Today: Making a Difference for a Lifetime
Leslie Citrome, MD, MPH
In this presentation, Dr. Leslie Citrome discusses strategies to optimize adherence to treatment, including addressing side effects and offering different formulation options. Additionally, a comparison of available long-acting injectable formulations, including newly available agents and how to implement them in clinical practice will be addressed.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Differential Diagnosis and Treatment of Antipsychotic-related Movement Disorders
Laxman B Bahroo, DO
Use of dopamine receptor blocking agents (DRBAs) may result in a variety of extrapyramidal symptoms (EPS), such as akathisia, tardive dyskinesia, and drug-induced parkinsonism. In this presentation, Dr. Laxman Bahroo provides practical tools for the assessment and early detection of movement disorders and how to differentiate between the various types of movement disorders, along with the most current individualized treatment approaches to effectively manage symptoms.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
So Many Options, So Little Focus: Navigating the World of ADHD Medications
David W Goodman, MD, FAPA
In this presentation, Dr. David Goodman explores the various options for pharmacological and nonpharmacological treatments to help address the needs of individual patients.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Update on the Assessment and Treatment of Eating Disorders
Leslie Citrome, MD, MPH
In this presentation, Dr. Leslie Citrome discusses the diagnostic criteria for the different eating disorder as well as their effective treatment modalities including certain specific psychotherapy and pharmacologic approaches.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
More Than Meets the Eye: Diagnosing and Treating Bipolar Depression
Stephen M Stahl, MD, PhD
It is often a challenge to successfully and efficiently diagnose bipolar depression as its presentation can be very difficult to distinguish from unipolar depression. However, the differential diagnosis is key as bipolar and unipolar depression have very different treatment strategies. Here, Dr. Stephen Stahl reviews the factors that may help with recognizing when a major depressive is part of a bipolar presentation as well as optimal strategies for treating patients with bipolar depression.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Adding Insult to Injury: The Challenge of Pseudobulbar Affect
Andrew J Cutler, MD
Pseudobulbar affect (PBA) is a disorder of affect characterized by bouts of laughing and or crying that are incongruous with a person's mood. In this presentation, Dr. Andrew Cutler will provide the latest hypotheses regarding the underlying causes and neurobiology of PBA. Strategies to address the underlying dysfunctional neurocircuitry of PBA using pharmacological agents will also be discussed.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Legislation and Legalization of Marijuana Use: How to Protect the Patient
Kari L Franson, PharmD, PhD
You have questions, Dr. Franson has answers. Learn what evidence (if any) exists for the common conditions for which cannabis is used, the potential risks of long-term use, and some key considerations to convey to patients.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
PsychopharMYTHology: Beliefs Widely Held by Psychopharmacologists That Are Actually Not True
Rajnish Mago, MD
There are some myths surrounding psychopharmacology we know to be clearly untrue, such as ‘the same prescriptions work for everyone’ or ‘your patients will feel better immediately’. However, in this presentation Dr. Rajnish Mago discusses more challenging misconceptions psychopharmacologists may encounter.
CME credits: 1.25
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Is It Safe? Using Psychotropics in Patients With Hepatic Issues
Jonathan M Meyer, MD
Dr. Jonathan Meyer discusses the most important issues in patients with hepatic dysfunction, and provides a practical method for assessing dosage adjustment for medications in patients with hepatic dysfunction.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Cases of Comorbid Substance Use
Roger S McIntyre, MD, FRCPC
Substance use—past or current—can complicate the treatment decisions for patients with mental illness. Here, Dr. McIntyre presents cases that illustrate the dilemmas and offers guidance for these complicated situations
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Psychiatric Emergency: Assessment and Management of Agitation
Rona J Hu, MD
Agitation is a serious and potentially dangerous consequence of many psychiatric conditions. In this presentation, Dr. Rona Hu explores the neurobiology of aggressive behaviors and discusses pharmacological and non-pharmacological strategies for ameliorating agitation and preventing the escalation to violence in patients with mental illness.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
What's Shakin': Brain Stimulation Therapies for Psychiatric Disorders
William M Sauvé, MD
For patients with treatment-resistant depression, stimulation therapies such as transcranial magnetic stimulation (TMS) have significantly decreased depressive symptoms. Recently, there has been an explosion of novel research on the utilization of TMS to treat a variety of mental disorders beyond depression, such as obsessive compulsive disorder. In this presentation, Dr. William Sauvé provides an exciting update on current applications of brain stimulation techniques for the treatment of neuropsychiatric conditions.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
If You Treat Schizophrenia You Must Prescribe Clozapine: Here's Why and How
Jonathan M Meyer, MD
In this presentation, Dr. Jonathan Meyer offers a practical perspective for utilizing clozapine in treatment resistant schizophrenia as well as reviews clozapine’s unique side effect profile, including how to manage drug interactions and common early adverse effects.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
Impact, Diagnosis, and Treatment of Personality Disorders
Thomas L Schwartz, MD
Personality disorders are often best thought of in dimensional terms versus discrete entities and often are highly comorbid with other psychiatric disorders making categorical diagnosis and resultant studies very difficult. In this presentation, Dr. Thomas Schwartz will discuss the impact, diagnosis, comorbidities, and treatment of personality disorders.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Psychosis and Dementia in Parkinson's Disease and Other Alpha-Synucleinopathies
Jonathan M Meyer, MD
Neurodegenerative disorders, such as Parkinson's disease present increasingly prevalent health issues in society today, and patients may present with dementia, psychosis, and agitation. The accumulation of α-synuclein protein into Lewy body inclusions is a hallmark feature of Parkinson's disease and other neurodegenerative disorders. In this presentation, Dr. Jonathan Meyer addresses the important role that alpha-synucleinopathies have in neurodegenerative disorders and the most effective treatment strategies available.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
Treatment-Resistant Depression: Current Best Practices and a Look to the Future
Roger S McIntyre, MD, FRCPC
One-third of depressed patients do not achieve an adequate clinical response to available treatment and are considered to have treatment-resistant depression. In this presentation, Dr. Roger McIntyre discusses new research and therapeutic options for identifying and treating resistant depression.
CME credit: 1.00
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|
|
|
A Primer on CAMs for Peripartum Depression
Stephen M Stahl, MD, PhD
Women who experience depression during the peripartum period are often uncomfortable utilizing conventional pharmacotherapies due to issues such as concern for the developing fetus. As such, many women turn to use of complementary and alternative medicines (CAMs) in order to reduce their symptoms of depression. In this presentation, Dr. Stephen Stahl explores the safety and efficacy of a variety of CAMs including both herbal and physical remedies.
CME credit: 0.75
Get Started
Download slides (PDF)
Download audio: Click to listen or right click to download
|
|